Trade margins on 137 cancer drugs capped, but will bills get lower? - The Times of India
Govt’s move to cap trade margins at 30% of MRP on 137 cancer drugs, covering over 1,000 medicine brands, puts the focus on actual patient savings, with effective implementation and monitoring needed to ensure it translates into lower medical bills.